HETEROBICYCLO-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES
                        
                            
                                申请人:Merck Sharp & Dohme Corp.
                            
                            
                                公开号:US20170197991A1
                            
                            
                                公开(公告)日:2017-07-13
                            
                            Disclosed are compounds of Formula G1:
where “R
G3
”. “R
d1
” to “R
d4
”, “n”, “m”, “p”, “W”, “X”, “Y”, and “Z” are defined herein, which compounds are antagonists of A
2A
receptor. Disclosed herein also are uses of the compounds described herein as antagonists of the A
2A
receptor in the potential treatment or prevention of neurological disorders and diseases in which A
2A
receptors are involved. Disclosed herein also are pharmaceutical compositions comprising these compounds and uses of these pharmaceutical compositions.